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ternal to NIOSH do not constitute NIOSH endorsement of the sponsoring organizations 
or their programs or products. Furthermore, NIOSH is not responsible for the content of 
these websites. All Web addresses referenced in this document were accessible as of the 
publication date.
Ordering Information
To receive documents or other information about occupational safety and health topics, 
contact NIOSH at
Telephone: 1–800–CDC–INFO (1–800–232–4636) 
TTY: 1–888–232–6348 
CDC INFO: www.cdc.gov/info
or visit the NIOSH website at www.cdc.gov/niosh.
For a monthly update on news at NIOSH, subscribe to NIOSH eNews by visiting www.cdc. 
gov/niosh/eNews.
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Foreword
Occupational exposure to chemical carcinogens still presents risks to many in the work-
force. The burden from exposure to occupational carcinogens on workers, their families, 
employers, and the nation is difficult to measure. Cases are missed and go unreported be-
cause of the length of time, often decades, between exposure to a carcinogen and resultant 
cancer and because cancers can also have non-occupational causes, making it difficult to 
determine causation in individual cases. To aid in the prevention of occupational cancer, 
the National Institute for Occupational Safety and Health (NIOSH) develops guidance to 
protect workers from adverse effects of occupational carcinogens. This effort has spanned 
more than 40 years. In this current document, the policy by which NIOSH classifies chemi-
cals as carcinogens, identifies control levels, and addresses analytical feasibility is being up-
dated because of advances in science and with the intent of providing transparent guidance 
on how NIOSH assesses and addresses cancer risks.
Underlying this policy is the NIOSH mandate to: 
“… describe exposure levels that are safe for various periods of employment, including but 
not limited to exposure levels at which no employee will suffer impaired health or function-
al capacities or diminished life expectancy as a result of his work experience.” [29 United 
States Code (USC) 669 (a)(3) and for mining, 30 USC 811 (a)(1) and 30 USC 811 (a)(6)(B)].
In general, previous guidelines were premised on an assumption that it was not scientifi-
cally possible to predict safe levels of exposure to carcinogens; therefore, risks at low doses 
(i.e., below the observable range) have been estimated using linear extrapolation.  However, 
there is emerging scientific evidence that the response at low doses of some carcinogens 
may be nonlinear, and may include a threshold. In these situations, simple linear extrapola-
tion at low doses may result in overestimation of cancer risk. Thus, this policy allows for 
nonlinear extrapolation for chemical carcinogens with sufficient supporting evidence of a 
nonlinear response. Above all, NIOSH will use an evidence-based approach to characterize 
carcinogenic risks in the workplace. 
This policy no longer uses the term recommended exposure limit (REL) for chemical car-
cinogens; rather NIOSH will only recommend an initial starting point for control, called 
the Risk Management Limit for Carcinogens (RML-CA). For each chemical identified as an 
occupational carcinogen, NIOSH will set the RML-CA at a risk of one excess cancer case in 
10,000 workers in a 45-year working lifetime when analytically feasible. 
When measurement of the occupational carcinogen at the RML-CA is not analytically fea-
sible at the 1 in 10,000 risk estimate, NIOSH will set the RML-CA at the limit of quanti-
fication (LOQ) or reliable quantitation limit (RQL) of the analytical method. In addition, 
NIOSH will continue to evaluate available information on existing engineering controls 
and also make that information available when publishing the RML-CA.
The foundation on which the NIOSH chemical carcinogen policy is built is cancer hazard 
classification. To avoid government duplication and to utilize transparent and systematic 
assessments, NIOSH will evaluate existing cancer hazard assessments completed by the U.S. 
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Department of Health and Human Services (HHS) National Toxicology Program (NTP), 
the U.S. Environmental Protection Agency (EPA) Integrated Risk Information System 
(IRIS), and the World Health Organization International Agency for Research on Cancer 
(IARC). 
John Howard, M.D.  
Director, National Institute for Occupational 
   Safety and Health 
Centers for Disease Control and Prevention 
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Executive Summary
Occupational cancer is a burden on workers and society. The National Institute for Occupa-
tional Safety and Health (NIOSH) has a long history of identifying occupational chemical 
carcinogens and recommending approaches to control them. To better clarify how it will 
address reducing exposures to occupational chemical carcinogens, NIOSH revised its 1995 
Chemical Carcinogen Policy. This newly revised Chemical Carcinogen Policy governs how 
NIOSH classifies chemicals as occupational carcinogens, sets risk management limits for 
workers exposed to carcinogens, and incorporates information on the analytical limit of 
quantification (LOQ) or the reliable quantitation limit (RQL) of the analytical method.
Chemical Carcinogen Classification
Under this policy, NIOSH authoritative publications relating to chemical carcinogens will 
evaluate existing cancer hazard assessments completed by the U.S. National Toxicology 
Program (NTP), the U.S. Environmental Protection Agency (EPA), and the International 
Agency for Research on Cancer (IARC), whenever possible. Reliance on these preexisting 
hazard assessments and cancer classifications will allow NIOSH to focus its resources on 
assessing occupational risks and recommending ways of reducing those risks. 
NIOSH will determine whether a chemical under consideration for the development of an 
authoritative recommendation is an occupational carcinogen by using one of the three fol-
lowing methods: (1) evaluation of chemical carcinogen hazard assessments developed by 
the U.S. Department of Health and Human Services (HHS) National Toxicology Program 
(NTP), the U.S. Environmental Protection Agency (EPA) Integrated Risk Information Sys-
tem (IRIS), and/or the World Health Organization International Agency for Research on 
Cancer (IARC); (2) nomination by NIOSH for Classification by NTP; or (3) classification 
by NIOSH. 
As part of its determination, NIOSH will review each chemical carcinogen hazard assess-
ment, in conjunction with the information noted in the Chemical Carcinogen Policy’s In-
dustrial Usage and Hazard Assessment and Scientific Studies sections, to determine if the 
chemical meets the criteria of occupational relevance. Those chemicals that meet the rel-
evance criteria will be designated “occupational carcinogens.” 
Risk Management Limit
NIOSH will continue to recommend reduction of exposure to an occupational carcinogen 
according to the hierarchy of controls through elimination or substitution and implementa-
tion of engineering controls, if practical, and the use of administrative controls before use 
of personal protective equipment (PPE). When exposures to carcinogens cannot be elimi-
nated, NIOSH will also (1) calculate a range of risk estimates, from 1 excess cancer case in 
100 workers to 1 excess cancer case in 1 million workers over a 45-year working lifetime 
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when the data permit, and (2) set a risk management limit for carcinogens (RML-CA). 
When data permit NIOSH to complete a quantitative risk assessment (QRA), NIOSH will 
use the results of the QRA to perform both tasks.
NIOSH will no longer use the term REL for occupational carcinogens. Instead, NIOSH will 
use the term risk management limit for a carcinogen or RML-CA to acknowledge that, for 
most carcinogens, there is no known safe level of exposure. RML-CA is a reasonable starting 
place for controlling exposures. An RML-CA is the daily maximum 8-hour time-weighted 
average concentration of a carcinogen above which a worker should not be exposed.
NIOSH acknowledges that some chemicals may have an exposure level below which carci-
nogenesis is not anticipated. The nonlinear response of these carcinogens will be addressed 
in any ensuing NIOSH guidance on exposure to these chemicals. However, risk manage-
ment based on a premise of no safe level does provide employers with a uniform approach 
to handling occupational carcinogens, including those with possible thresholds, that is 
easier to apply across different work processes and is more health-protective for workers. 
NIOSH will set the RML-CA for an occupational carcinogen at the estimated 95% lower 
confidence limit on the concentration (e.g., dose) corresponding to  1 in 10,000 (10-4) ex-
cess lifetime risk, when analytically possible to measure. Historically, NIOSH issued recom-
mended exposure limits (RELs) for carcinogens based on an excess risk level of 1 in 1,000 
(10-3). This level of risk was recommended because it could be analytically measured and 
achieved in many workplaces. However, in the last 25 years, advances in exposure assess-
ment, sensor and control technologies, containment, ventilation, risk management, and 
safety and health management systems have made it possible, in many cases, to control oc-
cupational chemical carcinogens to a lower exposure level. Therefore, in order to incremen-
tally move toward a level of exposure to occupational chemical carcinogens that is closer to 
background, NIOSH will begin issuing recommendations for RML-CAs that would advise 
employers to take additional action to control chemical carcinogens when workplace expo-
sures result in excess risks greater than 10-4. 
Analytical Feasibility and Engineering Achievability
The ability to measure chemicals in the workplace is an important consideration for both 
evaluating and controlling worker exposures. When measurement of the occupational car-
cinogen at the RML-CA is not analytically feasible at the 1 in 10,000 risk estimate, NIOSH 
will set the RML-CA at the limit of quantification (LOQ) or the reliable quantitation limit 
(RQL) of the analytical method for that occupational carcinogen. In addition, NIOSH will 
continue to evaluate available information on existing engineering controls and make that 
information available when publishing RML-CAs.
Peer Review and Public Comment
NIOSH will continue its policy of seeking public and stakeholder input on its comprehen-
sive analyses and recommendations, submitting them to peer review, and then publishing 
an authoritative document containing the recommendations and all supporting analyses 
recommending practices to control worker exposures.
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1 Introduction 
Purpose and Scope
Occupational cancer is a burden on workers and 
society. The National Institute for Occupational 
Safety and Health (NIOSH) has a rich history of 
identifying occupational carcinogens and recom-
mending approaches to control them. Although 
progress has been made, much work needs to be 
done. NIOSH developed this Chemical Carcino-
gen Policy because clear policies on how to clas-
sify chemicals as occupational carcinogens, set risk 
management limits for workers exposed to car-
cinogens, and incorporate information on the ana-
lytical limit of quantification (LOQ) or the reliable 
quantitation limit (RQL) leads to further progress 
in reducing the risk and occurrence of occupation-
al cancer. 
Since 1970 NIOSH has reviewed evidence on chem-
ical carcinogenicity to support recommended expo-
sure limits (RELs). Under the Occupational Safety 
and Health Act of 1970 and the Federal Mine Safety 
and Health Act of 1977, NIOSH is mandated to 
“...develop criteria dealing with 
toxic materials and harmful physi-
cal agents and substances which will 
describe exposure levels that are safe 
for various periods of employment, 
including but not limited to exposure 
levels at which no employee will suf-
fer impaired health or functional ca-
pacities or diminished life expectancy 
as a result of his work experience.” 
[29 United States Code (USC) 669 
(a)(3) and for mining, 30 USC 811 
(a)(1) and 30 USC 811 (a)(6)(B)]. 
NIOSH does so by undertaking an independent 
analysis of the scientific evidence on a chemical’s car-
cinogenicity, evaluating how and where the chemi-
cal may be used in the workplace, and quantitatively 
estimating the risk to workers at various exposure 
levels. NIOSH seeks public comment on these com-
prehensive analyses and recommendations, submits 
them to peer review, and then publishes an authori-
tative document containing the recommendations 
and all supporting analyses. These documents, 
usually Current Intelligence Bulletins or Criteria 
Documents, take significant resources to prepare.   
Three policies from NIOSH are updated in this 
document: (1) the NIOSH Occupational Chemical 
Carcinogen Classification Policy, (2) the Carcinogen 
Risk Management Limit Policy, and (3) the Analyti-
cal Feasibility and Engineering Achievability Policy. 
Together, these three policies are referred to as the 
NIOSH Carcinogen Policy. The goal is to simplify 
the process of assessing cancer risks so that the 
documents NIOSH produces are more useful for 
its stakeholders, timelier, and more consistent with 
those of other agencies that assess cancer risks. 
In performing this policy review, NIOSH sought 
suggestions and information from a range of or-
ganizations and the public. NIOSH published a re-
quest for information and held a public meeting to 
discuss the issues in December 2011. Information 
and comments from the public were submitted to 
NIOSH Docket 240: Announcement of Carcinogen 
and Recommended Exposure Limit (REL) Policy 
Assessment. NIOSH carefully considered this in-
formation and then prepared an initial draft Cur-
rent Intelligence Bulletin, “Update of NIOSH Car-
cinogen Classification and Target Risk Level Policy 
for Chemical Hazards in the Workplace.” NIOSH 
again held a public meeting in December 2013 
and sought comments from stakeholders and 
the public. Comments were submitted to NIOSH 
Docket 240A. NIOSH also solicited input from 
peer reviewers (see http://www.cdc.gov/niosh/
review/peer/HISA/carcinogen-pr.html). 
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NIOSH carefully considered this critical infor-
mation in revising its policies on (1) classifying 
chemicals as occupational carcinogens, (2) setting 
risk management limits for occupational carcino-
gens, and (3) incorporating information about the 
analytical LOQ or RQL for chemical carcinogens 
in the workplace. This document announces and 
explains these revised policies. 
The science of risk assessment and carcinogenic-
ity research is rapidly advancing. The policies de-
scribed in this document are intended to provide 
transparent guidance on how NIOSH assesses can-
cer risks. They are not intended to constrain agency 
judgement such that strict adherence leads to as-
sessments that do not represent current scientific 
thinking or assessments that are not suitable for the 
range of factors considered when assessing an indi-
vidual chemical hazard. NIOSH will note and ex-
plain any variations in its practices when assessing 
cancer risks. NIOSH will also continue to engage 
scientific peers, stakeholders, and the public in the 
development and review of its assessments. NIOSH 
expects to update these policies as new science or 
agency experience indicates that these policies may 
have become outdated. 
History of NIOSH Carcinogen 
Classification and REL Setting  
To understand the changes that NIOSH is making 
to the policy for classifying chemical carcinogens, 
it helps to know the history of NIOSH efforts to 
classify workplace carcinogens.
1975: First NIOSH Carcinogen Policy
NIOSH first presented its carcinogen classifica-
tion guidelines at the Conference on Occupational 
Carcinogenesis organized by the New York Acad-
emy of Sciences [Fairchild 1976]. The NIOSH 
guidelines recommended “no detectable exposure 
levels for proven carcinogenic substances.” Under 
these guidelines, NIOSH classified a chemical as a 
carcinogen in two ways:
1. Any substance which is shown conclusively to 
cause tumors in animals should be considered 
carcinogenic and therefore a potential cancer 
hazard to man.
2. All tumorigens must be regarded as potential 
carcinogens, i.e., agents which produce benign 
tumors should be considered to be capable of 
producing malignant tumors.
The 1975 NIOSH cancer guidelines, were premised 
on the then-dominant assumption that it was not 
scientifically possible to predict safe levels of ex-
posure to carcinogens. The NIOSH approach was 
consistent with that of the Occupational Safety and 
Health Administration (OSHA) and other national 
and international agencies at that time. For ex-
ample, the 1958 Delaney Clause, an amendment to 
the 1938 Food, Drug and Cosmetic Act, stated that 
“the Secretary of the Food and Drug Administra-
tion [FDA] shall not approve for use in food any 
chemical additive found to induce cancer in man, 
or, after tests, found to induce cancer in animals.” 
FDA interpreted the Delaney Clause as requiring it 
to ban the use as a food additive of any substance 
shown to cause cancer in animals. Scientists voiced 
strong support for extending the Delaney Clause 
principles more broadly to environmental and oc-
cupational carcinogens [Fairchild 1976].
OSHA Cancer Policy 
In 1977, OSHA published a Proposed Rule on the 
Identification, Classification, and Regulation of 
Toxic Substances Posing a Potential Occupational 
Carcinogenic Risk (“OSHA Cancer Policy”) [42 
Fed. Reg. 54148]. OSHA faced the task of regulat-
ing many potential occupational carcinogens. In 
each rulemaking, many similar questions arose 
about how to identify and classify carcinogens and 
how much evidence of cancer-causing potential 
was needed to support OSHA regulation. The pro-
posed OSHA Cancer Policy was designed to provide 
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a consistent framework for addressing these recur-
ring issues. The proposed OSHA Cancer Policy de-
fined a “potential occupational carcinogen” as
“…any substance or combination or 
mixture of substances, which causes 
an increased incidence of benign 
and/or malignant neoplasms, or a 
substantial decrease in the latency 
period between exposure and onset 
of neoplasms in humans or in one 
or more experimental mammalian 
species as the result of any oral, 
respiratory, or dermal exposure, or 
any other exposure which results 
in the induction of tumors at a site 
other than the site of administra-
tion. This definition also includes any 
substance that is metabolized into 
one or more potential carcinogens by 
mammals” [29 CFR 1990.103].
OSHA published the final Cancer Policy on January 
22, 1980. The Cancer Policy created two classes of 
potential occupational carcinogens: Category I Po-
tential Occupational Carcinogens were those with 
evidence of cancer-causing potential in humans or 
in animal tests that had been confirmed in another 
species, and Category II Potential Occupational 
Carcinogens were those for which the evidence of 
cancer-causing potential was “suggestive” [29 CFR 
1990.112]. The Cancer Policy provided that when 
OSHA initiated rulemaking concerning a Category 
I Potential Occupational Carcinogen, the permis-
sible exposure limit (PEL) should be set at the low-
est feasible level [29 CFR 1990.142(a)(2)(iii)]. 
The requirement that OSHA set the PEL for Cat-
egory I Potential Occupational Carcinogens at the 
lowest feasible level was short-lived. In July 1980, 
the Supreme Court issued an opinion in American 
Petroleum Institute v. Industrial Union Department 
[448 U.S. 607 (1980)] (commonly referred to as the 
Benzene decision). In Benzene the Supreme Court 
rejected the OSHA policy of automatically setting 
the PEL for a potential occupational carcinogen 
at the lowest feasible level. Instead, the Supreme 
Court read section 3(8) of the OSH Act, 29 U.S.C. 
653(8), the section which defines an occupational 
safety and health standard, to require that OSHA 
find “as a threshold matter that the toxic substance 
in question poses a significant health risk in the 
workplace and that a new, lower standard is there-
fore ‘reasonably necessary and appropriate’ to pro-
vide safe” workplaces [448 US at 14–15]. 
In response to the Benzene decision, OSHA pub-
lished revisions to its Cancer Policy that deleted 
those provisions which required that the Agency 
automatically set the PEL for a Category I potential 
occupational carcinogen at the lowest feasible level 
[46 Fed. Reg. 4889]. OSHA also noted that “most 
provisions of the cancer policy are not affected 
by the Benzene decision. These include scientific 
policies, priority setting, identification criteria and 
classification criteria.” 
1978: NIOSH Adopts “Potential 
Occupational Carcinogen”
In its 1978 testimony on the proposed OSHA Can-
cer Policy, NIOSH expressed general support for 
the definition of “potential occupational carcino-
gen” but recommended the following categories for 
carcinogens [NIOSH 1978b]:
Category I: Probable (or Confirmed) Occupa-
tional Carcinogen
Category II: Suspect Occupational Carcinogen
Category III: Carcinogenic Evidence Incon-
clusive
NIOSH began using the term potential occupa-
tional carcinogen to describe the carcinogenic po-
tential of chemicals in the workplace shortly after 
its testimony on the OSHA Cancer Policy, in the 
Criteria for a Recommended Standard: Occupa-
tional Exposure to Glycidyl Ethers [NIOSH 1978a]. 
Since 1978, NIOSH has continued to use the term 
potential occupational carcinogen, without distin-
guishing between carcinogen categories in many 
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NIOSH Criteria Documents, Current Intelligence 
Bulletins, and testimony in OSHA standard-setting 
hearings. 
NIOSH has decided to continue its approach of 
using one label for classifying all known and sus-
pected chemical carcinogens. Although NIOSH 
recognizes the value of a tiered system in carcino-
gen classification for hazard communication, in 
practice, once a chemical has been designated a 
potential occupational carcinogen, the NIOSH risk 
management guidance has been the same. There-
fore, NIOSH has decided not to adopt another 
tiered system as, without changing the NIOSH rec-
ommended risk management approach, it would 
complicate and confuse the process of carcinogen 
classification. 
Until 1995, NIOSH had also set RELs at the low-
est feasible concentration for occupational chemi-
cal carcinogens. NIOSH summarized its policy as 
follows: 
“When thresholds for carcinogens 
that would protect 100% of the 
population had not been identified, 
NIOSH usually recommended that 
occupational exposures to carcino-
gens be limited to the lowest feasible 
concentration.” [NIOSH Pocket 
Guide to Chemical Hazards 
(Appendix A) [NIOSH 2007].
In testimony to OSHA in 1988 for rulemaking on 
air contaminants, NIOSH used the phrases “lowest 
feasible limit,” “lowest feasible level,” and “fullest 
extent feasible” interchangeably when describing 
how “potential occupational carcinogens” should 
be controlled in the workplace. NIOSH stated “… 
that work practices and engineering controls such 
as substitution, isolation, and ventilation should 
be used to control occupational exposures to 
the fullest extent feasible” [NIOSH 1988, p. 20]. 
Phrases such as “lowest feasible concentration” 
were recommended by NIOSH for controlling 
exposures to carcinogens until a change in policy 
occurred in 1995. 
1995: NIOSH Projects Health Risks 
for Carcinogens
NIOSH revised its policy regarding exposure limits 
for carcinogens in 1995 to provide a more quantita-
tive basis for RELs, including those for chemicals 
that were classified as potential occupational car-
cinogens:
“NIOSH recommended exposure 
limits (RELs) will be based on risk 
evaluation using human or animal 
health effects data, and on an assess-
ment of what levels can be feasibly 
achieved by engineering controls and 
measured by analytical techniques. 
To the extent feasible, NIOSH will 
project not only a no-effect exposure, 
but also exposure levels at which 
there may be residual risks. This 
policy applies to all workplace haz-
ards, including carcinogens…” [1995 
policy cited in NIOSH 2007]. 
In accordance with this policy, most NIOSH RELs 
for carcinogens developed since 1995 have been 
based on (1) quantitative assessments of projected 
health risks at various exposure concentrations 
and (2) assessments of the feasibility of accurately 
measuring and controlling exposures to the haz-
ard in the workplace [NIOSH 1995; NIOSH 2016; 
NIOSH 2013].
Since NIOSH revised its policy in 1995, NIOSH has 
most frequently recommended exposure limits for 
toxic chemicals, both those that are potentially car-
cinogenic and those that are not, at concentrations 
corresponding to an excess risk of 1 in 1,000 workers 
exposed to the substance for a 45-year working life-
time. The 1995 criteria document for coal mine dust 
discussed 1 in 1,000 as a risk level for chronic and 
serious respiratory health effects that did not involve 
cancer. Both the 2011 Current Intelligence Bulletin 
for titanium dioxide and the 2013 Criteria Docu-
ment for hexavalent chromium compounds used 1 
in 1,000 as the risk level for carcinogenic effects in 
setting RELs [NIOSH 1986, 1995, 2011a, 2013].
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Under the 1995 policy, NIOSH also considered the 
“feasibility” of analytical methods [NIOSH 1994] 
in establishing RELs for some carcinogens. For ex-
ample, the 1995 policy resulted in some RELs for 
carcinogens being set at the LOQ of the analytical 
method, resulting in a higher REL than would have 
been established if based solely on an assessment of 
the health risk.
This page intentionally left blank.
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2 Classifications of Chemical Carcinogens by NTP, 
EPA, and IARC 
Under this newly revised policy, authoritative 
documents produced by NIOSH addressing 
chemicals thought to cause cancer will evaluate 
existing cancer hazard assessments completed by 
the U.S. National Toxicology Program (NTP), the 
U.S. Environmental Protection Agency (EPA), and 
the International Agency for Research on Cancer 
(IARC), whenever possible. Reliance on these pre-
existing hazard assessments and cancer classifica-
tions will allow NIOSH to focus its resources on 
assessing occupational risks and recommending 
ways of reducing those risks. 
The NIOSH proposal to use  the hazard assess-
ments already completed by NTP, EPA, and/or 
IARC found strong support in peer and public 
comments on the proposal. Commenters agreed 
that NIOSH reliance on hazard assessments com-
pleted by one of these agencies would increase 
NIOSH efficiency and allow it to focus its re-
sources on estimating the magnitude of the risk a 
chemical poses to workers and recommendations 
for mitigating those risks. 
Some industry commenters objected to NIOSH 
reliance on NTP, EPA, and or IARC hazard analy-
ses, claiming that NIOSH should rely on a weight-
of-evidence approach. Several commenters iden-
tified NTP consideration of the cancer causing 
potential of styrene as illustrative of the fact that 
NTP does not use a weight-of-evidence approach 
in classifying potential carcinogens. However, a 
thorough review conducted by the National Re-
search Council (NRC) of the National Academy of 
Sciences found that the basis for the NTP cancer 
classification of styrene was sound [NRC 2014].
NIOSH believes carcinogen classification should 
employ a systematic methodology for critically 
assessing and interpreting a body of scientific 
information. This methodology should include 
specific steps for the evaluation and integration 
of scientific information: defining a question 
or stating a problem of interest (causal question 
definition); creating a review protocol; identify-
ing and selecting relevant information; evaluating 
individual studies (review of individual studies); 
assessing and integrating evidence across studies 
and providing an overall synthesis (data integra-
tion and evaluation); and interpretation of find-
ings (drawing conclusions based on inferences) 
[Rhomberg et al, 2013]. These steps are important 
and are utilized by EPA, NTP, and IARC in their 
chemical carcinogen determinations. This type 
of review is critical for assessing and classifying 
chemical carcinogenicity. Whether this process is 
called “weight of evidence,” “strength of evidence,” 
“integration of evidence,” or “systematic review,” 
the important issue is that steps in the critical 
evaluation of chemical carcinogenicity should be 
made explicit [Weed 2005]. 
NTP, EPA, and IARC each describe their scientific 
approach as employing a thorough, systematic 
analysis of the body of evidence or evaluation of 
the strength of evidence using a transparent pro-
tocol and integration of evidence across studies. 
Each of these approaches for critically assessing 
and interpreting a body of scientific evidence sat-
isfies NIOSH criteria. 
For those chemicals that NIOSH is assessing, 
NIOSH will review the hazard assessment of 
chemicals with any of the cancer classifications 
listed in Table 2-1. Chemicals with classifications 
that fall within any of these categories will be 
treated similarly by NIOSH as it assesses the risk 
posed to workers.
8 NIOSH CIB 68 • NIOSH Chemical Carcinogen Policy
Table 2-1. NTP, EPA, and IARC carcinogen classifications NIOSH considers when assessing 
occupational chemicals. 
Organization Carcinogen classification




Carcinogenic to humans, likely to be carcinogenic to humans or suggestive 
evidence of carcinogenic potential
EPA
(1986 criteria)
Group A, Group B1, Group B2, or Group C
IARC Group 1, Group 2A, or Group 2B
Known to be a Human Carcinogen
There is sufficient evidence of carcinogenicity 
from studies in humans,* which indicates a causal 
relationship between exposure to the agent, sub-
stance, or mixture, and human cancer.
Reasonably Anticipated to be a Human Carcinogen
A chemical may be classified as reasonably antici-
pated to be a human carcinogen if any one of the 
following three circumstances apply,
(1) There is limited evidence of carcinogenic-
ity from studies in humans,* which indi-
cates that causal interpretation is credible, 
but that alternative explanations, such as 
chance, bias, or confounding factors, could 
not adequately be excluded,
(2) There is sufficient evidence of carcinogenic-
ity from studies in experimental animals, 
which indicates there is an increased inci-
dence of malignant and/or a combination of 
malignant and benign tumors 
(i) in multiple species or at multiple tissue sites, 
*This evidence can include traditional cancer epidemiology studies, 
data from clinical studies, and/or data derived from the study of 
tissues or cells from humans exposed to the substance in question, 
which can be useful for evaluating whether a relevant cancer mech-
anism is operating in humans.
NIOSH views the assessments produced by NTP, 
IARC, and EPA to be of the highest scientific qual-
ity, subject to extensive peer review or prepared by 
acknowledged experts in the field in a consensus-
building process. Below, NIOSH describes the key 
features of the cancer classifications of NTP, EPA, 
and IARC that give NIOSH confidence to rely upon 
them for its hazard assessment of occupational car-
cinogens.
National Toxicology Program
NTP publishes the Report on Carcinogens (RoC), a 
congressionally mandated listing of chemicals that 
are known to be human carcinogens or reasonably 
anticipated to be human carcinogens. As of 2014, 
the RoC contains 243 listings and is updated peri-
odically. NIOSH is a founding member of the NTP, 
has a representative on the NTP Executive Com-
mittee, has input into prioritization of chemicals at 
NTP, and has a vote in all procedural matters. 
NTP Carcinogen 
Classification Criteria
The NTP listing categories are: (1) Known to be a 
Human Carcinogen and (2) Reasonably Anticipat-
ed to be a Human Carcinogen [NTP 2016]. 
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(ii) by multiple routes of exposure, or 
(iii) to an unusual degree with regard to in-
cidence, site, type of tumor, or age at 
onset; or
(3) There is less than sufficient evidence of carci-
nogenicity in humans or laboratory animals, 
but the agent, substance, or mixture belongs 
to a well-defined, structurally related class 
of substances whose members are listed in 
a previous RoC as either known to be a hu-
man carcinogen or reasonably anticipated 
to be a human carcinogen, or there is 
convincing relevant information that the 
agent acts through mechanisms indicating 
it would likely cause cancer in humans. 
NTP Procedures 
NTP completes a hazard assessment of each chemi-
cal it evaluates. The hazard assessment evaluates 
relevant information on dose response, route of ex-
posure, chemical structure, metabolism, toxicoki-
netics, sensitive subpopulations, genetic effects, or 
other data that relate to mode of action or factors 
that may be unique to a given chemical. NTP does 
not quantify the potential cancer risk. On the basis 
of a careful review and integration of the body of 
evidence, NTP classifies the chemical. 
Any person can nominate an agent for listing in the 
NTP RoC. Once an agent is nominated, NTP pre-
pares a background document for peer review at 
a public meeting. Next, NTP prepares a chemical 
profile document that provides a detailed analy-
sis of the published scientific evidence relating to 
the potential cancer effects of the chemical. On the 
basis of this comprehensive analysis, NTP recom-
mends a listing.
The chemical profile and recommended listing are 
then circulated to an external scientific panel for 
peer review. The draft chemical profile and recom-
mended listing are then revised on the basis of the 
peer review comments and made available for pub-
lic comment. NTP revises the profile after consid-
eration of those comments and submits the revised 
RoC to HHS for final review and approval.
These procedures comprise a thorough, systematic 
review of the literature and a careful integration of 
the body of evidence, followed by peer and pub-
lic review. These procedures are consistent with 
NIOSH requirements for hazard classification.
EPA Integrated Risk 
Information System 
The EPA IRIS program conducts hazard analysis 
and quantitative risk assessments of chemicals. (See 
http://www.epa.gov/iris/.) Other EPA program of-
fices then rely on these assessments to implement 
the statutes they administer, and IRIS relies upon 




EPA adopted cancer guidelines in 1986 and revised 
those guidelines in 2005. When the EPA published 
the 2005 guidelines, it did not reclassify all the 
chemicals that had been classified under the 1986 
EPA guidelines. For that reason, both systems are 
explained here (Tables 2-2 and 2-3).
1986 EPA Cancer Guidelines
Under the 1986 guidelines, EPA provided a sum-
mary of the weight of evidence regarding a chemi-
cal’s potential as a human carcinogen and placed 
the chemical (agent) into one of the five categories 
in Table 2-2.
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Table 2-2. 1986 Definitions of EPA carcinogen classifications.
Carcinogen classification Definition
Group A
Carcinogenic to humans 
Agents with adequate human data to demonstrate the causal 
association of the agent with human cancer (typically  
epidemiologic data)
Group B
Probably carcinogenic to humans 
Agents with sufficient evidence (that is, indicative of a causal 
relationship) from animal bioassay data but either limited human 
evidence (that is, indicative of a possible causal relationship, but 
not exclusive of alternative explanations; Group B1) or little or no 
human data (Group B2)
Group C
Possibly carcinogenic to humans 
Agents with limited animal evidence and little or no human data
Group D
Not classifiable as to human 
carcinogenicity 
Agents without adequate data either to support or refute human 
carcinogenicity
Group E
Evidence of non-carcinogenicity 
for humans 
Agents that show no evidence for carcinogenicity in at least two 
adequate animal tests in different species or in both adequate 
epidemiologic and animal studies
2005 EPA Cancer Guidelines
The 2005 EPA guidelines recommend a chemical’s 
human carcinogenic potential be described in a 
“weight-of-evidence narrative” that gives a summa-
ry of available evidence relevant to cancer, as well as 
uncertainties and key default assumptions used, and 
describes conditions associated with a chemical’s 
hazard potential. Preference is given to information 
reported in peer-reviewed scientific journals. 
The 2005 guidelines rely on five cancer classifica-
tions as described in Table 2-3.
EPA Procedures
EPA develops a narrative describing the poten-
tial for a chemical’s carcinogenicity, relying on a 
weight-of-evidence analysis that includes any limi-
tations based on dose-rate or dependence on mode 
of action. EPA emphasizes understanding the 
mechanism by which a chemical causes cancer to 
determine whether the mode of action is relevant 
to humans. This understanding is based on animal 
findings, risks to sensitive populations or life stages 
(for which the EPA has issued supplemental guid-
ance), and evaluation of risk assessment options.
The EPA IRIS Assessment Development Process 
provides formal steps for extensive scientific peer 
and public review [EPA 2016]. EPA bolstered the 
opportunities for public comment and peer review 
in 2011 in response to comments from the National 
Academy of Sciences [EPA 2016]. 
These procedures comprise a thorough, systematic 
review of the literature and a careful weighing of 
the evidence, followed by peer and public review. 
These procedures are consistent with NIOSH re-
quirements for hazard classification.
International Agency for 
Research on Cancer
IARC serves as an international research agency 
on cancer and is a unit within the World Health 
Organization. IARC established its cancer classi-
fication criteria system in 1971, and it was among 
the earliest organizations to classify carcinogens. 
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Table 2-3. 2005 Definitions of EPA carcinogen classifications.
Carcinogen classification Definition
Carcinogenic to humans Requires convincing epidemiologic evidence of a causal association 
between human exposure and cancer. In cases where a causal 
association is not evident, the descriptor can indicate “strong” 
evidence of an association in humans, along with extensive evidence of 
carcinogenicity in animals by a similar mode of action.
Likely to be carcinogenic 
to humans
Requires a plausible association between human exposure and cancer. 
Evidence can include data from animal experiments in more than one 
species, gender, strain, site, or exposure route, with or without evidence 
of carcinogenicity in humans. The effects of metabolites, tumor type, 
tumor onset, or rarity are considered.
Suggestive evidence of 
carcinogenic potential 
Indicates a concern that the chemical may be a potential human 
carcinogen even though data for a stronger conclusion may be absent. 
Available data may include studies showing a small increase in tumor 
incidence; some studies with positive results and others with negative 
results; or studies whose power, design, or conduct limits the ability to 
draw a confident conclusion.
Inadequate information to 
assess carcinogenic potential
Indicates there is not enough available data to apply one of the other 
descriptors.
Not likely to be carcinogenic 
to humans 
Shows available data are considered robust enough to support the 
conclusion that the chemical is not likely to cause cancer in humans. 
When animal experiments show positive cancer results, strong evidence 
must show that the mode of action does not take place in humans.
The IARC adopted its most recent criteria in 2006. 
IARC produces well-respected “Monographs on 
the Evaluation of Carcinogenic Risks to Humans.” 




The IARC classification system includes the five 
categories in Table 2-4.
Table 2-4. Definitions of IARC carcinogen classifications.
Carcinogen classification Definition
Group 1 
Carcinogenic to humans 
Is based on sufficient evidence in humans; a causal relationship has 
been established between exposure to the agent and human cancer, 
or the animal evidence is sufficient, and there is strong mechanistic 
evidence in exposed humans that the agent or mixture acts through 
a carcinogenic mode of action relevant to humans. 
(Continued)
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Carcinogen classification Definition
Group 2A 
Probably carcinogenic to humans 
Indicates limited evidence in humans and sufficient evidence in 
animals. Alternatively, a chemical may be classified as Group 2A if 
there is inadequate evidence in humans but sufficient evidence in 
animals and strong evidence that the mechanism acts in humans. 
Group 2B 
Possibly carcinogenic to humans 
Indicates limited evidence in humans and less-than-sufficient 
evidence in animals; insufficient evidence in humans but sufficient 
evidence in animals; or animal evidence is limited, but there are 
other supporting data.
Group 3 
Not classifiable as to 
carcinogenicity to humans 
Is based on inadequate evidence in humans and inadequate or 
limited evidence in animals. This classification can also be made if 
there is sufficient evidence in animals and strong evidence that the 
mechanism does not act in humans.
Group 4 
Probably not carcinogenic 
to humans 
Is a rarely used category. A Group 4 chemical has strong and 
consistent evidence of lack of carcinogenicity in humans 
and animals.
IARC Procedures
The overall evaluation of evidence of carcinogenic-
ity considers three types of data: animal, human, 
and mechanistic. The animal or human evidence is 
classified by the expert Working Group as sufficient, 
limited, inadequate, or suggesting lack of carcinoge-
nicity. IARC describes its approach as “evaluations 
of the strength of the evidence for carcinogenicity 
arising from human and experimental animal data 
. . . The strength of the mechanistic evidence is also 
characterized.” The initial category is based on the 
combined level of evidence from the animal or hu-
man data. Strong mechanistic data can provide evi-
dence for raising or lowering the initial category.
The IARC review process includes procedures to 
select chemicals [IARC 2006]. Teams of interna-
tional experts conduct IARC assessments for each 
chemical. The IARC defines procedures and crite-
ria for selecting Working Group members, invited 
specialists, representatives of national and inter-
national health agencies, and observers. Working 
Group members must have no conflicts of interest; 
individual specialists may have affiliations, constit-
uencies, or research support that would represent a 
conflict of interest. The goal of IARC assessments is 
to reach a broad consensus among working group 
members regarding the carcinogenicity of agents 
under consideration. According to IARC, the tasks 
of Working Group members are 
“to ascertain that all appropriate data have 
been collected; (ii) to select the data relevant 
for the evaluation on the basis of scientific 
merit; (iii) to prepare accurate summaries of 
the data to enable the reader to follow the rea-
soning of the Working Group; (iv) to evaluate 
the results of epidemiological and experimen-
tal studies on cancer; (v) to evaluate data 
relevant to the understanding of mechanisms 
of carcinogenesis; and (vi) to make an overall 
evaluation of the carcinogenicity of the expo-
sure to humans.” 
There is concerted effort by IARC to obtain inter-
national expertise and reflect a variety of scientific 
Table 2-4 (Continued). Definitions of IARC carcinogen classifications.
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views and findings. The Working Group meetings 
provide for the presence of observers and repre-
sentatives from national and international health 
organizations. The names and affiliations of all par-
ticipants are made public. 
This systematic evaluation of all relevant data by 
recognized experts with consensus building on the 
carcinogen assessment are consistent with NIOSH 
requirements for hazard classification. 
This page intentionally left blank.
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3 Explanation of NIOSH Chemical Carcinogen Policy
NIOSH Occupational Chemical 
Carcinogen Classification Policy
NIOSH will determine whether a chemical under 
consideration for the development of an authorita-
tive recommendation is an occupational carcino-
gen by using one of the three following methods: 
(1) evaluation of chemical carcinogen hazard as-
sessments developed by the U.S. Department of 
Health and Human Services (HHS) National Tox-
icology Program (NTP), the U.S. Environmental 
Protection Agency (EPA) Integrated Risk Infor-
mation System (IRIS), and/or the World Health 
Organization International Agency for Research on 
Cancer (IARC); (2) nomination by NIOSH for Clas-
sification by NTP; or (3) classification by NIOSH.†
Evaluation of NTP, EPA and 
IARC Carcinogen Classification 
Hazard Assessments 
Review of Existing Carcinogen Classifications
NIOSH will initiate a review and evaluation of the 
occupational relevance of a chemical carcinogen that 
meets one or more of the designations in Table 3-1.
†The NIOSH Chemical Carcinogen Policy does not cover NIOSH 
evaluation of hazardous drugs. Hazardous drugs include those that 
exhibit one or more of the following six characteristics in humans 
or animals: (1) Carcinogenicity (2) Teratogenicity or other devel-
opmental toxicity (3) Reproductive toxicity (4) Organ toxicity at 
low doses (5) Genotoxicity or (6) Structure and toxicity profiles 
of new drugs that mimic existing drugs determined hazardous by 
the above criteria. NIOSH hazardous drug evaluation is consistent 
with the NIOSH Chemical Carcinogen Policy in that both include 
consideration of carcinogenicity and genotoxicity, both utilize in-
formation from IARC, NTP and EPA and both emphasize critically 
assessing and interpreting a body of scientific evidence. However, 
NIOSH evaluation of hazardous drugs is tailored to identify and 
evaluate data from human toxicity profiles, animal studies and in 
vitro studies unique to evaluating therapeutic agents. For example, 
NIOSH consults a variety of resources including but not limited to 
safety data sheets, product labeling approved by the U.S. Food and 
Drug Administration and databases such as DailyMed and Drug-
Bank. For more information on NIOSH hazardous drug evaluation 
see “NIOSH List of Antineoplastic and Other Hazardous Drugs in 
Healthcare Settings,” http://www.cdc.gov/niosh/index.htm. 
Table 3-1. NTP, EPA, and IARC carcinogen 
classifications NIOSH considers when 
assessing occupational chemicals.
Organization Carcinogen classification
NTP “Known to be human 
carcinogen” or “reasonably 




“Carcinogenic to humans, 
“likely to be carcinogenic 
to humans” or “suggestive 




Group A, Group B1, Group 
B2, or Group C
IARC‡ “Group 1,” “Group 2A,” or 
“Group 2B”
*NIOSH will not review assessments developed by EPA 
using 2005 criteria that result in a finding of “inadequate 
information to assess carcinogenic potential” or “not likely 
to be carcinogenic to humans.”
†NIOSH will not review assessments developed by EPA using 
1986 criteria that are included in Groups D or E.
‡NIOSH will not review assessments developed by IARC that 
are included in Group 3 or 4.
NIOSH reviews each chemical carcinogen hazard 
assessment, in conjunction with the information 
noted in the Industrial Usage and Hazard Assess-
ment and Scientific Studies sections, to determine 
if the chemical meets the criteria of occupational 
relevance. By evaluating the hazard assessment of 
NTP, IARC, or EPA, NIOSH will increase the num-
ber of cancer assessments it can complete without 
sacrificing the scientific quality of those assess-
ments. OSHA is also considering “ways to reduce 
the time and resources needed to independently 
evaluate the available study data by placing greater 
reliance on the efforts of other credible scientific 
organizations” [79 Fed. Reg. 61384].
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Occupational Relevance Review
NIOSH will evaluate whether the chemical is like-
ly to pose a risk in the occupational environment 
and whether the data underlying the cancer clas-
sification is applicable to the occupational setting. 
NIOSH will presume that a chemical classified 
as a carcinogen is occupationally relevant unless 
NIOSH finds convincing evidence that the chemi-
cal carcinogen is not relevant for the occupational 
exposure situation. This is because there are likely 
only very rare instances in which a chemical classi-
fied as a carcinogen by NTP, EPA, or IARC would 
not also be potentially carcinogenic to exposed 
workers. NIOSH will consider the issues described 
below in deciding whether a chemical is relevant to 
the occupational environment. 
Industrial Usage Review
NIOSH will review if information from current 
industrial usage indicates the potential for worker 
exposure to the chemical. NIOSH will review each 
chemical carcinogen hazard assessment and any 
additional information on current chemical pro-
duction and use, worker exposure data, and job 
descriptions where the chemical may be used, by 
means of peer-reviewed, published scientific stud-
ies, and other authoritative sources, including mar-
ket analyses. Where such peer-reviewed literature 
is not available on chemical use and workplace 
exposures, NIOSH will rely upon other reliable 
research to determine whether a chemical poses a 
potential cancer threat to workers.  
Typical workplace chemical exposures occur 
through inhalation or skin contact (although in 
special cases, oral exposures from hand-to-mouth 
routes or unique situations such as exposure 
through needle-stick injuries may be considered). 
Assessing the potential for worker exposure may in 
some cases identify ephemeral chemical intermedi-
ates that are produced only in closed systems. Work-
ers are not likely to be routinely exposed to these 
intermediates in the workplace. However, NIOSH 
will also consider the potential for release into the 
work environment as the result of a spill or explosion. 
In general, NIOSH will assume that inhalation and 
dermal studies are occupationally relevant because 
these are the typical exposures that workers en-
counter. NIOSH will also frequently consider stud-
ies with different routes of exposure, such as oral or 
injection studies, especially for carcinogens that act 
systemically. For example, animal studies in which 
exposure to the chemical is administered via drink-
ing water, food, or intraperitoneal injection may 
provide relevant information about worker risks 
due to occupational exposure. Conversely, there 
may be cases where a chemical acts locally and only 
at an injection site. NIOSH may determine these 
types of studies do not establish that a chemical is 
occupationally relevant. 
Hazard Assessment and  
Scientific Studies Review
NIOSH will review information and scientific 
studies relied upon by NTP, EPA, or IARC in devel-
oping each chemical carcinogen hazard assessment 
to determine (1) if the assessment is not relevant 
to occupational exposure or (2) if new information 
casts doubt on the scientific credibility of the as-
sessment. Under such circumstances, NIOSH will 
either nominate the chemical to NTP for review or 
conduct a full review of the evidence and classify 
the chemical itself. This review will include con-
sideration of route of exposure, tumor site, mode 
of action, and any other scientific information that 
may have bearing on the occupational relevance of 
the carcinogen classification.
NIOSH review may take place years after another 
entity completed its cancer hazard assessment and 
carcinogen classification. New studies may become 
available during the interim. NIOSH will consider 
whether the new studies would potentially change 
the overall evaluation. Such information may in-
crease the concern for a carcinogen (for example, 
supporting an upgrade of a classification to “known 
to be carcinogenic to humans”). More infrequently, 
it may decrease the concern (for example, owing 
to new information showing that studies support-
ing a classification of “reasonably anticipated to be 
carcinogenic to humans” were conducted using a 
17NIOSH CIB 68 • NIOSH Chemical Carcinogen Policy
substance containing a carcinogenic contaminant, 
casting doubt on the classification of the substance 
of interest). NIOSH will review evidence from any 
high quality, peer-reviewed, scientific study pub-
lished after NTP, EPA, or IARC completed its haz-
ard assessment (for example, an occupationally rel-
evant scientific study published subsequent to the 
final record of studies contained in the underlying 
hazard assessment) to determine if the study sug-
gests that the chemical no longer meets the criteria 
for the type of classification that NIOSH accepts for 
occupational relevance review. Under such circum-
stances, NIOSH will either nominate the chemical 
for NTP review or conduct a full evaluation of the 
information and classify the chemical itself.  
Occupational Relevance Evaluation 
NIOSH will determine whether the chemical is 
occupationally relevant and classify it as a NIOSH 
occupational carcinogen when there is a potential 
for worker exposure and the hazard assessments 
and scientific studies are applicable to occupational 
exposures. NIOSH will display the specific cancer 
classification each agency assigns to the chemical. 
NIOSH will also include the analysis in a NIOSH 
authoritative document describing the risks posed 
by the chemical in question.
Once NIOSH adopts the hazard assessment for a 
chemical, NIOSH will periodically review any re-
vised NTP, EPA, and IARC hazard assessment and 
carcinogen classifications for that chemical and will 
update its determination as necessary to ensure the 
determination remains scientifically sound.
The 1995 NIOSH classification scheme did not dis-
tinguish between chemicals that are classified as 
carcinogens on the basis of multiple, occupational 
epidemiology studies, such as asbestos, benzene 
and cadmium, and those classifications that are 
based on extrapolations from animal bioassay data 
or other scientific information, such as titanium di-
oxide. NIOSH has been criticized because the 1995 
policy does not allow for classifying chemicals on 
the basis of the magnitude and sufficiency of the 
scientific evidence. 
Despite this criticism, NIOSH will continue to rely 
on a single cancer designation—that of occupa-
tional carcinogen. There are several reasons for this 
NIOSH decision. NIOSH has concluded that cre-
ating another cancer classification scheme, when 
several already exist, is unnecessary. NIOSH will 
evaluate classifications and analyses done by other 
entities. It will display the classification each entity 
has assigned to the chemical. What is important is 
the systematic evaluation of the scientific evidence 
of carcinogenicity that each entity relies upon to 
justify its classification. For chemicals that have 
been classified with certain designations, NIOSH 
will use the hazard assessment that supported the 
classification and review it to determine that it is 
comprehensive and up to date. NIOSH has deter-
mined it is unnecessary for it to duplicate these 
preexisting scientific analyses. Once NIOSH de-
termines that a chemical is an occupational car-
cinogen, the cancer classification tier to which it is 
assigned has little relevance for NIOSH risk man-
agement recommendations. Therefore, the agency 
sees little to be gained by developing another tiered 
classification system. 
The shift from a designation of “potential occu-
pational carcinogen” to “occupational carcinogen” 
should not be interpreted as an effort by NIOSH 
to ignore the fact that the evidence of carcinoge-
nicity for some chemicals is stronger than it is for 
other chemicals. For those chemicals that NIOSH 
is assessing, once sufficient evidence indicates that 
a chemical is reasonably expected to pose a can-
cer risk to workers, NIOSH will move forward to 
estimate the magnitude of that risk and make rec-
ommendations for reducing the risk and protecting 
workers from harm.  
Nomination by NIOSH for 
Classification by NTP 
NIOSH may nominate a chemical for review by 
NTP when NIOSH has determined that the 
chemical has the potential for worker exposure 
and (a) there is no prior carcinogen classifica-
tion by NTP, EPA, or IARC or (b) information 
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in the occupational relevance evaluation indicates 
the need for reconsideration of the evidence.
Classification by NIOSH
If the chemical is of particular concern to NIOSH, 
NIOSH may develop its own hazard assessment of 
the chemical. In this assessment, NIOSH may clas-
sify the chemical as an occupational carcinogen 
when NIOSH has determined that the chemical 
has the potential for worker exposure and (a) there 
is no prior carcinogen classification by NTP, EPA, 
or IARC or (b) information in the occupational 
relevance evaluation indicates the need for recon-
sideration of the evidence underlying a published 
chemical carcinogen assessment.
When developing a new chemical carcinogen clas-
sification, NIOSH will use the criteria for carcino-
genicity contained in the United Nations’ Globally 
Harmonized System for Classification and Label-
ling of Chemicals (GHS) that have been incor-
porated into the Occupational Safety and Health 
Administration (OSHA) Hazard Communication 
Standard 29 CFR §1910.1200 and any interpreta-
tion of the GHS criteria issued by OSHA. NIOSH 
will use the GHS criteria to assess carcinogenic-
ity. If NIOSH determines that the evidence for a 
chemical corresponds to GHS class 1A, 1B, or 2, 
then NIOSH will designate the substance an “oc-
cupational carcinogen.” Under the OSHA Hazard 
Communication Standard, manufacturers and 
employers may make reasonable chemical assess-
ments that differ from those of government agen-
cies, such as NIOSH and NTP. But for purposes of 
NIOSH carcinogen classification, NIOSH will rely 
on the GHS criteria as the basis of its risk manage-
ment recommendations. 
Chemical Carcinogen Risk 
Management Limit Policy 
NIOSH will (1) determine a range of estimates 
from 1 excess cancer case in 100 workers to 1 
excess cancer case in 1 million workers in a 
45-year working lifetime when the data permit, 
and (2) set a risk management limit (RML-CA). 
NIOSH will continue to recommend reduction of 
exposure to an occupational carcinogen as much 
as possible through substitution or engineering 
controls and administrative controls before use of 
personal protective equipment (PPE). 
Determining a Range of Risk 
Estimates for Carcinogens
Quantitative Risk Assessment
After determining that a chemical is an occupation-
al carcinogen, NIOSH will assess whether data are 
suitable for performing a quantitative risk assess-
ment (QRA). If NIOSH determines that the data 
are suitable, NIOSH will perform a QRA based on 
the best available data. 
The discussion below summarizes key elements of 
the NIOSH approach to QRA. NIOSH expects to 
publish more comprehensive guidance describing 
its approach to risk assessment in the future. Un-
til then, NIOSH will continue to use the risk as-
sessment methods as more fully described in the 
NIOSH Criteria Document on Hexavalent Chro-
mium [NIOSH 2013] and Current Intelligence Bul-
letin on Titanium Dioxide [NIOSH 2011].
Evidence of Carcinogenicity
NIOSH bases its QRA on the best available data 
from human, animal, and/or mechanistic studies 
published in peer-reviewed scientific literature. 
The ideal data set for cancer risk estimation is an 
occupational epidemiology study with well-
documented exposures, work histories, and health 
effects and many years of follow-up. However, other 
human studies, animal cancer bioassays, in vitro 
data, and mechanistic studies can all play a role 
in estimating risks of exposure. When conduct-
ing a QRA, NIOSH evaluates the data sets that are 
most pertinent to the exposure-response relation-
ship and selects the data set(s) for analysis that can 
demonstrate a quantitative relationship. 
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Mathematical Models and 
Statistical Considerations
A QRA is used to estimate low-dose cancer risks 
by means of mathematical models to describe the 
exposure-response relationship. These statistical 
models project both a central estimate of the risk 
associated with occupational exposure and a statis-
tically derived confidence interval for that estimate. 
For carcinogen risk assessment, NIOSH generally 
treats exposure-response as low-dose linear unless 
a non-linear mode of action has been clearly estab-
lished, in which case NIOSH will adopt a modeling 
approach defined by the data (including non-linear 
approaches when appropriate). In general, whether 
the model forms are linear or non-linear, any non-
zero exposure to a carcinogen is expected to yield 
some excess risk of cancer. 
When practical, given the available data for QRA, 
NIOSH will project both a central estimate and 
a 95% lower confidence limit estimate of various 
exposure concentrations of interest. NIOSH will 
base its risk estimates on the 95% lower confidence 
limit, when it is feasible to do so. The central esti-
mate of risk is analogous to a mean or average con-
centration corresponding to a specific risk level, 
which in this example is 1 in 10,000. The 95% lower 
confidence limit is a measure of the imprecision 
in the risk estimate, and by using the 95% lower 
confidence limit as the basis for NIOSH risk esti-
mates, there is greater assurance that workers are 
protected to at least a risk level of 1 in 10,000 over 
a working lifetime. 
Mode of Action
The mode of action for carcinogens can affect the 
mathematical modeling assumptions and change 
the way a QRA is conducted. Genotoxic (“DNA-
damaging”) carcinogens are presumed to act via 
non-threshold mechanisms, and occupational 
exposure limits for these chemicals are typically 
based on low-dose linear models. 
Carcinogens that act through non-genotoxic mecha-
nisms (e.g., endocrine-modification, tumor-promotion, 
immunosuppression, and inflammation) or through 
indirect mechanisms (such as genotoxicity second-
ary to cytolethality and cell proliferation) may have 
responses at low doses that are nonlinear, including 
a threshold below which there is no added risk [Stre-
ffer et al., 2004]. Any potential threshold for a car-
cinogen can be adequately modeled by a sublinear, 
but non-threshold, mathematical model. Because of 
this, it is highly unlikely that one can demonstrate 
empirically that a threshold exists [Crump 2011]. 
Therefore, NIOSH acknowledges that even when a 
threshold cannot be empirically demonstrated, in 
some cases the true risk at low doses may be zero.
In practice, NIOSH has modeled the excess risk of 
cancer from a chemical believed to cause tumors 
in animals by a secondary genotoxic mechanism 
(for example, titanium dioxide), by fitting sub-linear 
but non-threshold models to the experimental 
data [NIOSH 2011]. In such a model, the excess 
risk of cancer is smaller at low doses than the risk 
that would be predicted by a linear model; howev-
er, some degree of excess risk is projected for any 
dose greater than zero. Therefore, like low-dose 
linear models, non-linear modeling approaches for 
non-genotoxic or indirectly genotoxic carcinogens 
imply that there will be some residual risk for any 
exposure greater than zero.
Sensitivity Analysis
The selection of final risk estimates upon which 
to base risk-management decisions depends on 
many factors in the QRA, including data source, 
biological relevance of the tumor site, modeling 
strategy, and biological plausibility of the model 
in the low-dose region, among many others. The 
best choice of a relevant and plausible set of op-
tions for risk assessment is not always evident. 
Therefore, NIOSH frequently conducts an analy-
sis of plausible and relevant alternatives, called a 
sensitivity analysis which makes explicit the impact 
of specific risk assessment choices on the final risk 
estimates. In this type of analysis, one might see, 
for example, the impact of selecting the best-fitting 
plausible model, the most health-protective plau-
sible model, or a weighted average of several mod-
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els that are each individually plausible. The specific 
risk assessment choices that are analyzed are de-
pendent upon the underlying risk assessment data 
and modeling choices but provide transparency on 
the impact of alternative analytical choices on the 
estimated concentration of a chemical carcinogen 
that is anticipated to produce a 1 in 10,000 lifetime 
excess risk of cancer.
Range of Risk Estimates
NIOSH will utilize the QRA to determine a range 
of risk estimates including 1 excess cancer case in 
100 workers, 1 excess cancer case in 1,000 work-
ers, 1 excess cancer case in 10,000 workers, 1 ex-
cess cancer case in 100,000 workers, and 1 excess 
cancer case in 1 million workers. NIOSH will 
project both a central estimate and a 95% lower 
confidence limit estimate of the dose producing 
excess cancer risk, when the data are scientifically 
suitable for doing so.
Setting a Risk Management Limit 
for Carcinogens
Historically, NIOSH issued recommended exposure 
limits (RELs) for carcinogens based on an excess risk 
level of 1 in 1,000 in a working lifetime. This level of 
risk was recommended because it could be measured 
and achieved in many workplaces. However, in the last 
25 years, advances in exposure assessment, sensor and 
control technologies, containment, ventilation, risk 
management, and safety and health management sys-
tems have made it possible in many cases to control 
chemical carcinogens to a lower exposure level. 
In keeping with these advances, NIOSH will set 
a “risk management limit for a carcinogen” or 
an “RML-CA,” at the concentration correspond-
ing to the 95% lower confidence limit of the 1 in 
10,000 risk estimate, but only when occupational 
measurement of the carcinogen at the RML-CA 
is analytically feasible. When measurement of 
the occupational carcinogen at the RML-CA is 
not analytically feasible at the 1 in 10,000 risk es-
timate, NIOSH will set the RML-CA at the limit 
of quantification (LOQ) or reliable quantitation 
limit (RQL) of the analytical method for that oc-
cupational carcinogen. NIOSH defines an RML-
CA as the maximum 8-hour time-weighted aver-
age concentration of an occupational carcinogen 
above which a worker should not be exposed. 
An excess lifetime risk level of 1 in 10,000 is consid-
ered to be a starting point for continually reducing 
exposures in order to reduce the remaining risk. 
NIOSH has established the terminology RML-CA 
instead of REL to acknowledgement that, for most 
carcinogens, there is no known safe level of expo-
sure. NIOSH acknowledges that some chemicals 
may have an exposure level below which carcino-
genesis is not anticipated. The nonlinear response 
of these carcinogens will be addressed accord-
ingly in any ensuing NIOSH guidance. However, 
in lieu of specific guidance, NIOSH believes that 
risk management based on the premise of no safe 
level is health-protective in most situations, and 
provides employers with an effective, simple, and 
unified approach to handling occupational car-
cinogens. NIOSH will continue to recommend 
that employers reduce worker exposure to occu-
pational carcinogens as much as possible through 
the hierarchy of controls, most importantly elimi-
nation or substitution of other chemicals that 
are known to be less hazardous, and engineering 
controls. Administrative controls, such as work 
practice controls, are also an important way to 
minimize workers’ exposures but are lower in the 
hierarchy. Personal protective equipment is the last 
line of defense, used when other methods do not 
adequately reduce exposures. Therefore, exposures 
should be kept below a risk level of 1 in 10,000, if 
practical. 
Finally, several public commenters urged NIOSH to 
provide only the exposure limits that correspond to 
various risk levels, such as 1 in 1,000, 1 in 10,000, 1 
in 100,000, or 1 in 1,000,000. Many of these com-
menters objected that NIOSH should not “rec-
ommend” one specific exposure level and should 
leave such a policy decision to OSHA. These com-
menters observed that NIOSH is a scientific re-
search agency and that OSHA is the agency that 
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is charged with making decisions about acceptable 
risks and feasibility. NIOSH agrees that it should 
provide information on the exposure levels that 
correspond to various levels of risk; however, 
NIOSH will continue to provide a health-based 
RML-CA to guide employers who seek to reduce 
exposures to occupational carcinogens to better 
protect their workers. 
Analytical Feasibility and 
Engineering Achievability Policy
A sampling and analytical method that can accu-
rately measure the exposure concentration over 
the recommended sampling period is necessary 
to assess occupational exposures below the RML-
CA. NIOSH evaluates the method used to measure 
worker exposures to determine the LOQ or RQL, 
which indicate how low a concentration can be re-
liably measured. It is important to identify a sam-
pling and analytical method that can accurately 
measure the chemical at the health-based RML-
CA (that is, the lower bound of the 1 in 10,000 ex-
cess cancer risk estimate), when it is available. Af-
ter deriving the RML-CA, NIOSH will determine 
whether a NIOSH or OSHA analytical method can 
accurately measure the carcinogen at the RML-
CA. If NIOSH determines that no partially or fully 
validated method is available, NIOSH will consider 
initiating research to develop a suitable method. 
When measurement of the occupational carcino-
gen is not analytically feasible at the lower bound 
of the 1 in 10,000 risk estimate, NIOSH will set 
the RML-CA at the LOQ or RQL of the analytical 
method for that occupational carcinogen.
Limit of Quantification
Several commenters criticized the NIOSH propos-
al to set the REL at the LOQ when the LOQ value is 
greater than the 1 in 1,000 cancer risk estimate pre-
sented in the public draft of this document. They 
urged that NIOSH should set the REL at the level 
necessary to protect worker health and not at some 
higher level. These commenters indicated that ana-
lytic methods change frequently, and a REL set at 
the LOQ will rapidly become out of date. Many of 
these commenters also suggested that NIOSH set 
two levels—the REL calculated to be health protec-
tive and the higher level suggested by the LOQ. 
The ability to measure chemicals in the workplace is 
an important consideration for both evaluating and 
controlling worker exposures. When the LOQ or RQL 
is greater than the lower bound of the 1 in 10,000 risk 
estimate, NIOSH will consider initiating research to 
improve the LOQ for the analytical method. In addi-
tion, NIOSH will revise the RML-CA when the LOQ 
or RQL for a NIOSH or OSHA validated or partially 
validated analytical method is reduced. 
Engineering Achievability
Section 6(b)(5) of the Occupational Safety and 
Health Act of 1970 (“Act”) requires OSHA to con-
sider feasibility when setting occupational safety 
and health standards. Section 20(a)(3) of the Act 
directs NIOSH to recommend criteria for toxic 
substances that ensure that no employee suffers 
impaired health. Section 20 does not mention 
feasibility. 
The science underlying the design and implemen-
tation of engineering controls is constantly ad-
vancing. Therefore, given the fast pace of rapidly 
changing engineering controls, NIOSH will not 
utilize the capability of controlling exposures (that 
is, engineering achievability) in setting RML-CAs. 
NIOSH will continue to recommend using a hier-
archy of controls to reduce exposures to workers. 
NIOSH will continue to evaluate existing informa-
tion on engineering controls and make that infor-
mation available to the public.
Peer Review and Public 
Comment
Peer Review and Public Comment
NIOSH will continue its policy of seeking public and 
stakeholder input on its comprehensive analyses and 
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recommendations, submitting them to peer review, 
and then publishing an authoritative document con-
taining the recommendations and all supporting 
analyses recommending practices to control worker 
exposures. These documents are usually Current Intel-
ligence Bulletins or Criteria Documents. NIOSH will 
seek peer review and public comment, consistent with 
the Office of Management and Budget's Information 
Quality Guidelines,‡,§ about a determination regarding 
(1) chemical hazard assessment and occupational rel-
evance reviews; (2) QRA for each occupational car-
cinogen, including but not limited to selection of data 
‡Office of Management and Budget. December 16, 2004. "Final Infor-
mation Quality Bulletin for Peer Review." See http://www.white-
house.gov/omb/memoranda_fy2005_m05-03
§Office of Management and Budget. "Final Bulletin for Agency Good 
Guidance Practices." January 18, 2007. See http://www.whitehouse.
gov/sites/default/files/omb/memoranda/fy2007/m07-07.pdf
and mathematical models; (3) analytical methods for 
measuring the RML-CA; and (4) information regard-
ing engineering controls. 
Federal Register Notice
After considering all comments it receives, NIOSH 
will publish in the Federal Register a notice whether a 
chemical has been determined by NIOSH to be an oc-
cupational carcinogen, the reasons for the NIOSH clas-
sification, the RML-CA, and the range of risk estimates. 
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4 NIOSH Chemical Carcinogen Policy
Three policies from the National Institute for 
Occupational Safety and Health (NIOSH) are 
updated in this document: (1) the NIOSH Oc-
cupational Chemical Carcinogen Classification 
Policy; (2) the Carcinogen Risk Management Limit 
Policy; and (3) the Analytical Feasibility and Engi-
neering Achievability Policy. Together, these three 
policies are referred to as the NIOSH Chemical 
Carcinogen Policy.
NIOSH Occupational Chemical 
Carcinogen Classification Policy 
NIOSH will determine whether a chemical under 
consideration for the development of an authorita-
tive recommendation is an occupational carcino-
gen, using one of the three following methods: (1) 
evaluation of chemical carcinogen hazard assess-
ments developed by the U.S. Department of Health 
and Human Services (HHS) National Toxicology 
Program (NTP), the U.S. Environmental Protec-
tion Agency (EPA) Integrated Risk Information 
System (IRIS), and/or the World Health Organiza-
tion International Agency for Research on Cancer 
(IARC); (2) nomination by NIOSH for Classifica-
tion by NTP; or (3) classification by NIOSH.
Evaluation of NTP, EPA and IARC 
Hazard Assessments
Review of Existing Carcinogen Classifications
NIOSH will initiate a review and evaluation of the 
occupational relevance for a chemical carcinogen 
that meets one or more of the following designa-
tions:
1. NTP: “Known to be human carcinogen” or “rea-
sonably anticipated to be human carcinogen;” 
2. EPA (2005 criteria): “Carcinogenic to humans,” 
“likely to be carcinogenic to humans,” or “sug-
gestive evidence of carcinogenic potential;”
Note: NIOSH will not review assessments de-
veloped by EPA using 2005 criteria that result 
in a finding of “inadequate information to assess 
carcinogenic potential” or “not likely to be carci-
nogenic to humans.”
3. EPA (1986 criteria): Group A, Group B1, Group 
B2, or Group C
Note: NIOSH will not review assessments de-
veloped by EPA using 1986 criteria that are in-
cluded in Groups D or E.
4. IARC: “Group 1,” “Group 2A,” or “Group 2B.”
Note: NIOSH will not review assessments devel-
oped by IARC that are included in Groups 3 or 4.
Occupational Relevance Review
NIOSH reviews each chemical carcinogen hazard 
assessment, in conjunction with the information 
noted in the Industrial Usage and Hazard Assess-
ment and Scientific Studies sections, to determine 
if the chemical meets the criteria of occupational 
relevance.
Industrial Usage Review
NIOSH will review if information from current 
industrial usage indicates the potential for worker 
exposure to the chemical.
NIOSH will review each chemical carcinogen haz-
ard assessment and any additional information on 
current chemical production and use, worker expo-
sure data, and job descriptions where the chemical 
may be used by means of peer-reviewed, published 
scientific studies, and other authoritative sources 
including, but not limited to, market analyses.
Hazard Assessment and Scientific 
Studies Review
NIOSH will review information and scientific 
studies relied upon by NTP, EPA, or IARC in devel-
oping each chemical carcinogen hazard assessment 
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to determine if the assessment is relevant to occu-
pational exposure. 
Note 1: During its evaluation of occupational 
relevance, if NIOSH finds a high quality, peer-
reviewed, scientific study that casts doubt on the 
scientific credibility of the hazard assessment, then 
NIOSH will either nominate the chemical to NTP 
for review or conduct a full review of the evidence 
and classify the chemical itself. 
Note 2: After NIOSH completes its evaluation of 
occupational relevance, if NIOSH finds a high 
quality, peer-reviewed, scientific study indicating 
that the chemical no longer meets the criteria for 
the type of classification that NIOSH accepts for 
occupational relevance review, then NIOSH will 
either nominate the chemical to NTP for review or 
conduct a full review of the evidence and classify 
the chemical itself. 
Occupational Relevance Determination 
NIOSH will determine whether the chemical is 
occupationally relevant and classify it as an occu-
pational carcinogen when there is a potential for 
worker exposure and the hazard assessment and 
scientific studies are applicable to occupational 
exposures.
Nomination by NIOSH for 
Classification by NTP
NIOSH may nominate the chemical for review by 
NTP when NIOSH has determined that the chemi-
cal has the potential for worker exposure and (a) 
there is no prior carcinogen classification by NTP, 
EPA, or IARC, or (b) if information in the occupa-
tional relevance evaluation indicates the need for 
reconsideration of the evidence. 
Classification by NIOSH 
NIOSH may perform its own chemical hazard 
assessment to determine if the chemical should 
be classified as an occupational carcinogen when 
NIOSH has determined that the chemical has the 
potential for worker exposure and (a) no prior 
carcinogen classification by NTP, EPA or IARC 
has been published or (b) information in the oc-
cupational relevance evaluation indicates the need 
for reconsideration of the evidence underlying a 
published chemical carcinogen assessment. When 
developing a new chemical carcinogen classifica-
tion, NIOSH will use the criteria for carcinogenic-
ity contained in the United Nations’ Globally Har-
monized System for Classification and Labelling of 
Chemicals (GHS), as included in the Occupational 
Safety and Health Administration (OSHA) Hazard 
Communication Standard.¶
Chemical Carcinogen Risk 
Management Limit Policy
When assessing the hazards of occupational car-
cinogens, NIOSH will (1) determine a range of risk 
estimates, from 1 excess cancer case in 100 work-
ers to 1 ex¬cess cancer case in 1 million workers in 
a 45-year working lifetime, when the data permit, 
and (2) set a risk management limit.
Determining a Range of Risk 
Estimates for Carcinogens
Quantitative Risk Assessment 
After determining that a chemical is an occupation-
al carcinogen, NIOSH will assess whether data are 
suitable for performing a quantitative risk assess-
ment (QRA). If NIOSH determines that the data 
are suitable, NIOSH will perform a QRA based on 
the best available data.
Range of Risk Estimates
NIOSH will utilize the QRA to determine a range 
of risk estimates, including 1 excess cancer case 
in 100 workers, 1 excess cancer case in 1,000 
workers, 1 excess cancer case in 10,000 workers, 
¶29 C.F.R 1910.1200 ("Hazard Communication").
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1 excess cancer case in 100,000 workers, and 1 ex-
cess cancer case in 1 million workers. NIOSH will 
project both a central estimate and a 95% lower 
confidence limit estimate of the exposure produc-
ing excess cancer risk when the data are scientifi-
cally suitable for doing so.
Setting a Risk Management 
Limit for Carcinogens
NIOSH will no longer use the term recommended 
exposure limit (REL) for occupational carcinogens. 
Instead, NIOSH will use the term risk management 
limit for a carcinogen (RML-CA). An RML-CA is 
the maximum 8-hour time-weighted average con-
centration of a carcinogen to which a worker may 
be exposed. 
Risk Management Limit
When data permit, and when measurement of the 
occupational carcinogen at the RML-CA is analyti-
cally feasible, NIOSH will set RML-CAs for occu-
pational carcinogens at the concentration corre-
sponding to the 95% lower confidence limit of the 
1 in 10,000 risk estimate.
When data permit, but measurement of the occu-
pational carcinogen at the lower confidence limit 
of the 1 in 10,000 risk estimate is not analytically 
feasible, NIOSH will set the RML-CA at the limit 
of quantification (LOQ) or the reliable quantitation 
limit (RQL) for the analytical method for that oc-
cupational carcinogen.
Analytical Feasibility and 
Engineering Achievability Policy
Analytical Feasibility
If NIOSH determines that there is no analytical 
method that is partially or fully validated that can 
reliably measure the occupational carcinogen at the 
lower bound of the 1 in 10,000 risk level, NIOSH 
will consider initiating research to develop a suitable 
analytical method for the occupational carcinogen.
Engineering Achievability
NIOSH will continue to evaluate existing informa-
tion on engineering controls and make that infor-
mation available to the public.
Peer Review and 
Public Comment
Peer Review and Public Comment 
NIOSH will seek peer review and public comment 
consistent with the Office of Management and 
Budget’s Information Quality Guidelines**,†† about 
a determination regarding (1) chemical hazard as-
sessment and occupational relevance reviews; (2) 
QRA for each occupational carcinogen, including 
selection of data and mathematical models; (3) an-
alytical methods for measuring the RML-CA; and 
(4) information regarding engineering controls.
Federal Register Notice
After peer review and public comment, NIOSH 
will publish in the Federal Register a notice wheth-
er a chemical has been determined by NIOSH to 
be an occupational carcinogen, the reasons for the 
NIOSH classification, the RML-CA, and the range 
of risk estimates. 
**Office of Management and Budget. December 16, 2004. "Final 
Information Quality Bulletin for Peer Review. See http://www.
whitehouse.gov/omb/memoranda_fy2005_m05-03
††Office of Management and Budget. Final Bulletin for Agency Good 
Guidance Practices. January 18, 2007. See http://www.whitehouse 
gov/sites/default/files/omb/memoranda/fy2007/m07-07.pdf 
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